ecopipam has been researched along with Tourette Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkinson, SD; Cunniff, TM; Dubow, JS; Gilbert, DL; Mahableshwarkar, AR; Wanaski, SP | 1 |
| Black, KJ; Budman, CL; Chipkin, RE; Coffman, KA; Gilbert, DL; Grant, JE; Jankovic, J; Juncos, J; Kurlan, RM; McCracken, JT; Murphy, TK | 1 |
| Waddington, JL | 1 |
| Himle, M; Schrock, L; Shprecher, DR | 1 |
1 review(s) available for ecopipam and Tourette Syndrome
| Article | Year |
|---|---|
Neurobehavioral aspects, pathophysiology, and management of Tourette syndrome.
Topics: Alcohol Oxidoreductases; Aripiprazole; Benzazepines; Cerebellar Nuclei; Disease Management; Dopamine Antagonists; Humans; Mental Disorders; Mutation; Piperazines; Quinolones; Tourette Syndrome | 2014 |
2 trial(s) available for ecopipam and Tourette Syndrome
| Article | Year |
|---|---|
Ecopipam for Tourette Syndrome: A Randomized Trial.
Topics: Adolescent; Antipsychotic Agents; Child; Double-Blind Method; Humans; Severity of Illness Index; Tics; Tourette Syndrome; Treatment Outcome; Weight Gain | 2023 |
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
Topics: Adolescent; Benzazepines; Child; Cross-Over Studies; Dopamine Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Outcome Assessment, Health Care; Severity of Illness Index; Tourette Syndrome | 2018 |
1 other study(ies) available for ecopipam and Tourette Syndrome
| Article | Year |
|---|---|
Why does the goalkeeper eschew medication? The challenge of new treatments for tourette syndrome.
Topics: Benzazepines; Child; Cross-Over Studies; Humans; Receptors, Dopamine D1; Tourette Syndrome | 2018 |